| 注册
首页|期刊导航|中国肿瘤生物治疗杂志|NLR、PLR、LDH联合检测对转移性胃癌免疫治疗的预后价值

NLR、PLR、LDH联合检测对转移性胃癌免疫治疗的预后价值

吴世祯 林榕波

中国肿瘤生物治疗杂志2025,Vol.32Issue(2):189-198,10.
中国肿瘤生物治疗杂志2025,Vol.32Issue(2):189-198,10.DOI:10.3872/j.issn.1007-385x.2025.02.007

NLR、PLR、LDH联合检测对转移性胃癌免疫治疗的预后价值

Prognostic value of combined NLR,PLR and LDH evaluation in immunotherapy for metastatic gastric cancer

吴世祯 1林榕波2

作者信息

  • 1. 福建医科大学附属南平第一医院 肿瘤内科,福建 南平 353000
  • 2. 福建省肿瘤医院 消化肿瘤内科,福建 福州 350000
  • 折叠

摘要

Abstract

Objective:To explore the predictive value of combined evaluation of neutrophil to lymphocyte ratio(NLR),platelet to lymphocyte ratio(PLR),and lactate dehydrogenase(LDH)on the therapeutic effect and prognosis of ICIs(immune checkpoint inhibitors)in metastatic gastric cancer(MGC)patients.Methods:This study conducted a retrospective analysis of pre-and post-treatment peripheral hematological indicators of 88 MGC patients treated at Nanping First Hospital affiliated to Fujian Medical University.The recent treatment efficacy of the two patient groups was evaluated based on the solid tumor response evaluation criteria.χ2 tests were conducted to analyze and compare differences in disease control rate(DCR)and objective response rate(ORR),as well as differences in PD-L1 expression and clinical characteristics between the two groups.Survival analysis was performed using the Kaplan-Meier method for univariate analysis.Intergroup differences were detected by the Log-Rank test.Univariate analysis was conducted using the Cox proportional hazards regression model.Results:After immunotherapy,NLR3,NLR4,PLR2,PLR3,PLR4,LDH2 and LDH3 decreased significantly compared with those before treatment(all P<0.05).There were significant statistical differences in NLR1 and LDH1 before treatment between the complete-remission(CR)+partial-remission(PR)group and the progress-disease(PD)group(all P<0.05).Patients with higher levels of NLR2,NLR3,NLR4,PLR4,LDH1,LDH3,LDH4,ΔNLR1,ΔNLR2,ΔNLR3 and ΔPLR1 had shorter OS(all P<0.05),and patients with higher levels of NLR2,NLR3,NLR4,PLR1,LDH1,ΔNLR1,ΔNLR2,ΔNLR3,Δ PLR1 and Δ PLR2 had shorter PFS compared with patients in low-level group(all P<0.05).The percentage of PD-L1 negative patients among NLR3-H patients was the highest,and the number of NLR3-H patients in the NLR3-L group was larger than that in the negative group,the combined positive score(CPS)=1-5 group and the CPS≥5 group(all P<0.05).The proportion of women in the NLR3-H and PLR3-H groups was higher(all P<0.05).Conclusion:The evaluation of NLR,PLR,and LDH has certain value in predicting the efficacy and prognosis of immunotherapy for MGC.

关键词

转移性胃癌/免疫治疗/中性粒细胞与淋巴细胞比值/血小板与淋巴细胞比值/乳酸脱氢酶/预后价值

Key words

metastatic gastric cancer(MGC)/immunotherapy/neutrophil to lymphocyte ratio(NLR)/platelet to lymphocyte ratio(PLR)/lactate dehydrogenase(LDH)/prognostic value

分类

临床医学

引用本文复制引用

吴世祯,林榕波..NLR、PLR、LDH联合检测对转移性胃癌免疫治疗的预后价值[J].中国肿瘤生物治疗杂志,2025,32(2):189-198,10.

中国肿瘤生物治疗杂志

OA北大核心

1007-385X

访问量0
|
下载量0
段落导航相关论文